Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Endometrial Neoplasms × Tablets × Clear all

Sponsor

Conditions

Neoplasms 4 Leukemia, B-Cell 2 Urinary Bladder Neoplasms 1 Polycystic Ovary Syndrome 1 Parathyroid Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Hairy Cell 1 Leukemia 1 Hyperparathyroidism, Primary 1 Head and Neck Neoplasms 1 Diabetes Mellitus 1 Carcinoma, Renal Cell 1 Carcinoma 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

Paclitaxel 14 pembrolizumab 13 Carboplatin 10 rucaparib 5 lenvatinib 5 Megestrol Acetate 5 Bevacizumab 5 Radiation 4 Nivolumab 4 tisotumab vedotin 3 Indocyanine Green 3 Doxorubicin 3 temsirolimus 2 olaparib 2 ixabepilone 2 iso-sulfan blue 2 irosustat 2 copanlisib 2 Taxes 2 Sirolimus 2 Sentinel Lymph Node Biopsy 2 Metformin 2 Letrozole 2 Ipilimumab 2 Gemcitabine 2 Fulvestrant 2 Cisplatin 2 Brachytherapy 2 trastuzumab duocarmazine 1 talazoparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡